20
Hikal Limited Bangalore In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Partnering with Pharmaceutical, Life Sciences, Biotech & Specialty Chemicals Companies to deliver APIs, Intermediate & R&D Services.
One of their significant offerings is Olmesartan medoxomil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2017-239 - Rev 01
This Chemical Type CEP, issued on October 15, 2019, remains in force until November 09, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2600 associated with this CEP further emphasizes